{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:44:52Z","timestamp":1782899092341,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.106965","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T03:52:43Z","timestamp":1779767563000},"page":"106965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Heart failure and COPD - guideline adherence, diagnostic characterisation and treatment quality"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-476X","authenticated-orcid":false,"given":"Delphine","family":"Vauterin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1286-2014","authenticated-orcid":false,"given":"Nathaniel M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo M.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-4363","authenticated-orcid":false,"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106965_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106830","article-title":"Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation","author":"Vauterin","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106965_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106871","article-title":"Heart failure and COPD \u2013 Disentangling undertreatment from the impact of severe comorbidities","author":"Steffen","year":"2026","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2026.106965_bib0003","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ejhf.2083","article-title":"Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF","volume":"23","author":"Dewan","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.ejim.2026.106965_bib0004","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ejhf.3000","article-title":"Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER","volume":"25","author":"Butt","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10.1016\/j.ejim.2026.106965_bib0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2026.106965_bib0006","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ejim.2026.106965_bib0007","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jchf.2022.10.013","article-title":"Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization","volume":"11","author":"Moghaddam","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.ejim.2026.106965_bib0008","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med."},{"issue":"10","key":"10.1016\/j.ejim.2026.106965_bib0009","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2023-323487","article-title":"Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease","volume":"110","author":"Hawkins","year":"2024","journal-title":"Heart"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:43:18Z","timestamp":1782895398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":9,"alternative-id":["S0953620526002700"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106965","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure and COPD - guideline adherence, diagnostic characterisation and treatment quality","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106965"}}